Type-2 somatostatin receptor mRNA levels in breast and colon cancer determined by a quantitative RT-PCR assay based on dual label fluorogenic probe and the TaqMan™ technology

This publication has 17 references indexed in Scilit:

• Developments in Quantitative PCR
  cclm, 1998
• Somatostatin Receptors
  Trends in Endocrinology & Metabolism, 1997
• Somatostatin receptor subtypes sst1, sst2, sst3 and sst5expression in human pituitary, gastroentero-pancreatic and mammary tumors
  International Journal of Cancer, 1997
• A novel method for real time quantitative RT-PCR.
  Genome Research, 1996
• The somatostatin receptor family
  Life Sciences, 1995
• Molecular and pharmacological characterization of somatostatin receptor subtypes in adrenal, extraadrenal, and malignant pheochromocytomas
  Journal of Clinical Endocrinology & Metabolism, 1995
• Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms.
  Proceedings of the National Academy of Sciences, 1995
• Differential Expression of Five Somatostatin Receptor Subtypes, SSTR1-5, in the CNS and Peripheral Tissue
  Digestion, 1994
• Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
  Journal of Clinical Oncology, 1993
• Potential role of somatostatin analogues in the treatment of cancer
  European Journal of Clinical Investigation, 1987